BIIB

Biogen Inc. Common Stock

$309.06 -$0.40 -0.13%



Shares Bought7
Shares Sold7
Total14
Shares Owned0
Last Price$309.06
Total Return$34.44
Range Today$306.11 - $311.22
52 Week Range$244.28 - $348.84
Open$309.50
Market Cap$65.36B
Volume/Average533.45K/1.55M
P/E Ratio18.95
Dividend/Yield0.00




Biogen, Inc. is a global biotechnology company, which focuses on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. The company also collaborates on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA which is approved for the treatment of chronic lymphocytic leukemia. Biogen was founded by Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
07-26-17 16:08 07-28-17 18:30 $294.93 $287.42 -$7.51 -2.55% fafnerthedragon jcompton5
07-21-17 16:53 07-28-17 18:25 $282.48 $287.43 +$4.95 +1.75% n0mad1c1 schlafdecke
07-21-17 16:48 07-28-17 18:20 $282.36 $287.40 +$5.04 +1.78% xvpulsevx n0mad1c1 radiatoren
07-19-17 20:53 07-28-17 18:15 $283.04 $287.33 +$4.29 +1.52% n0mad1c1
07-19-17 20:33 07-28-17 18:10 $282.14 $287.50 +$5.36 +1.90% n0mad1c1
07-19-17 20:17 07-26-17 21:25 $283.03 $292.66 +$9.63 +3.40% eallen426 n0mad1c1 wolfiegaming_ eikiek
07-19-17 17:09 07-26-17 19:06 $282.41 $295.09 +$12.68 +4.49% n0mad1c1 fafnerthedragon